News

INVENTIVA: Inventiva reports 2025 First Quarter Financial Information
New York City (New York, United States), May 23, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) (the "Company"), a clinical-stage biopharmaceutical ...
Taiwan News4h
Inventiva reports 2025 First Quarter Financial Information¹
On January 29, 2025, Inventiva announced the publication in Journal of Hepatology of the results of the investigator-initiated proof-of-concept clinical trial led by Dr. Kenneth Cusi, demonstrating ...